AnnouncedFiled 16 December 2025
Imbria Pharmaceuticals, Inc. has sold $66.7M so far
Imbria Pharmaceuticals, Inc., a biotech company based in Boston, MA, has sold $66.7M so far in its equity round, according to a filing dated 16 December 2025.
Announced on 10 April 2025, 250 days before the filing. imbria.com ↗
- Filed
- 16 December 2025
- First filed
- 1 April 2025
- Round
- Equity round (amended filing)
- Amount sold
- $66.7M
- Offering size
- $144M
- Investors so far
- 10
- Based in
- Boston, MA
- Website
- imbria.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 92% of the 1,404 tracked raises with an amount filed in 2025, and than 84% of the 112 in biotech.
Imbria Pharmaceuticals, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 16 Dec 2025 | Amended filing | $66.7M | This raise |
More with AN on the board
- Pahr Therapeutics, Inc.$4.67M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.